Evaluation of Safety and Efficacy of Using Seraffix LTB - System for Excisional Biopsy Wounds Closure

NCT00525434 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-06-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of using Seraffix LTB system for excisional biopsy wounds closure

Conditions

  • Dehiscence, Surgical Wound

Interventions

DEVICE

Seraffix LTB

wounds closure by using laser and albumin

Sponsors & Collaborators

  • Seraffix

    lead INDUSTRY

Principal Investigators

  • Yehuda Ullmann, Dr. · RAMBAM Medical Center, Haifa Israel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-07-31
Completion
2009-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00525434 on ClinicalTrials.gov